PubMed:22752006 / 1234-1470 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T8","span":{"begin":0,"end":236},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":236},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":236},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Consistent with a homeostatic role of endogenous Gal1, patients with recurrent pregnancy loss showed considerably lower levels of circulating Gal1 and had higher frequency of anti-Gal1 auto-Abs in their sera compared with fertile women."}

{"project":"GO-BP","denotations":[{"id":"T2","span":{"begin":203,"end":207},"obj":"http://purl.obolibrary.org/obo/GO_0004617"},{"id":"T3","span":{"begin":222,"end":229},"obj":"http://purl.obolibrary.org/obo/GO_0009566"}],"text":"Consistent with a homeostatic role of endogenous Gal1, patients with recurrent pregnancy loss showed considerably lower levels of circulating Gal1 and had higher frequency of anti-Gal1 auto-Abs in their sera compared with fertile women."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T15","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G32871SU\""},{"id":"GlycanIUPAC_T16","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G32871SU\""},{"id":"GlycanIUPAC_T17","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G32871SU\""},{"id":"GlycanIUPAC_T24","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G07087RJ\""},{"id":"GlycanIUPAC_T25","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G07087RJ\""},{"id":"GlycanIUPAC_T26","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G07087RJ\""},{"id":"GlycanIUPAC_T33","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G40843KY\""},{"id":"GlycanIUPAC_T34","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G40843KY\""},{"id":"GlycanIUPAC_T35","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G40843KY\""},{"id":"GlycanIUPAC_T42","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G68158BT\""},{"id":"GlycanIUPAC_T43","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G68158BT\""},{"id":"GlycanIUPAC_T44","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G68158BT\""},{"id":"GlycanIUPAC_T51","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G75623HL\""},{"id":"GlycanIUPAC_T52","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G75623HL\""},{"id":"GlycanIUPAC_T53","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G75623HL\""},{"id":"GlycanIUPAC_T60","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G08908FU\""},{"id":"GlycanIUPAC_T61","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G08908FU\""},{"id":"GlycanIUPAC_T62","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G08908FU\""},{"id":"GlycanIUPAC_T69","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G38028NH\""},{"id":"GlycanIUPAC_T70","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G38028NH\""},{"id":"GlycanIUPAC_T71","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G38028NH\""},{"id":"GlycanIUPAC_T78","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G48426CT\""},{"id":"GlycanIUPAC_T79","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G48426CT\""},{"id":"GlycanIUPAC_T80","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G48426CT\""},{"id":"GlycanIUPAC_T87","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G34526ZS\""},{"id":"GlycanIUPAC_T88","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G34526ZS\""},{"id":"GlycanIUPAC_T89","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G34526ZS\""},{"id":"GlycanIUPAC_T96","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G25681JY\""},{"id":"GlycanIUPAC_T97","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G25681JY\""},{"id":"GlycanIUPAC_T98","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G25681JY\""},{"id":"GlycanIUPAC_T105","span":{"begin":49,"end":53},"obj":"\"http://rdf.glycoinfo.org/glycan/G75236KD\""},{"id":"GlycanIUPAC_T106","span":{"begin":142,"end":146},"obj":"\"http://rdf.glycoinfo.org/glycan/G75236KD\""},{"id":"GlycanIUPAC_T107","span":{"begin":180,"end":184},"obj":"\"http://rdf.glycoinfo.org/glycan/G75236KD\""}],"text":"Consistent with a homeostatic role of endogenous Gal1, patients with recurrent pregnancy loss showed considerably lower levels of circulating Gal1 and had higher frequency of anti-Gal1 auto-Abs in their sera compared with fertile women."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T8","span":{"begin":0,"end":236},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":236},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":236},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Consistent with a homeostatic role of endogenous Gal1, patients with recurrent pregnancy loss showed considerably lower levels of circulating Gal1 and had higher frequency of anti-Gal1 auto-Abs in their sera compared with fertile women."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T8","span":{"begin":0,"end":236},"obj":"Sentence"}],"text":"Consistent with a homeostatic role of endogenous Gal1, patients with recurrent pregnancy loss showed considerably lower levels of circulating Gal1 and had higher frequency of anti-Gal1 auto-Abs in their sera compared with fertile women."}